danazol has been researched along with Primary Myelofibrosis in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.17) | 18.7374 |
| 1990's | 4 (16.67) | 18.2507 |
| 2000's | 7 (29.17) | 29.6817 |
| 2010's | 8 (33.33) | 24.3611 |
| 2020's | 4 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Gale, RP; Li, B; Pan, L; Qin, T; Qu, S; Wu, J; Xiao, Z; Xu, Z; Yan, X; Zhang, P; Zhang, Y | 1 |
| Al-Ali, HK; Donahue, R; Egyed, M; Fox, ML; Gerds, AT; Goh, YT; Granacher, N; Grosicki, S; Gupta, V; Harrison, CN; Iurlo, A; Kawashima, J; Kiladjian, JJ; Klencke, BJ; Kuykendall, AT; Lavie, D; Lazaroiu, MC; Lee, SE; McLornan, D; Mesa, R; Ocroteala, L; Passamonti, F; Perkins, A; Ro, S; Vannucchi, AM; Verstovsek, S; Yoon, SS | 1 |
| Al-Ali, HK; Donahue, R; Egyed, M; Fox, ML; Gerds, AT; Goh, YT; Granacher, N; Grosicki, S; Gupta, V; Harrison, CN; Iurlo, A; Kawashima, J; Kiladjian, JJ; Klencke, BJ; Kuykendall, AT; Lavie, D; Lazaroiu, MC; Lee, SE; McLornan, D; Mesa, R; Ocroteala, L; Oh, S; Passamonti, F; Perkins, A; Vannucchi, AM; Verstovsek, S; Yoon, SS; Yu, J | 1 |
| Björkholm, M; He, J; Liwing, J; Löfgren, C; Schain, F; Song, C; Vago, E | 1 |
| Chen, CC; Egyed, M; Ellis, M; Fox, L; Goh, YT; Gupta, V; Harrison, C; Kiladjian, JJ; Kowalski, MM; Lazaroiu, MC; McLornan, D; McMullin, MF; Mead, A; Mesa, RA; Oh, ST; Perkins, A; Platzbecker, U; Scheid, C; Vannucchi, A; Verstovsek, S; Yoon, SS | 1 |
| Camoriano, J; Dueck, A; Gano, K; Gowin, K; Hoffman, R; Kosiorek, H; Mascarenhas, J; Mesa, R; Palmer, J; Reeder, C; Tibes, R | 1 |
| Fang, L; Hu, N; Huang, G; Li, B; Luo, X; Pan, L; Peter Gale, R; Qin, T; Qu, S; Xiao, Z; Xu, Z; Zhang, H; Zhang, P; Zhang, Y | 1 |
| Mesa, RA; Scherber, RM | 1 |
| Akashi, K; Kitanaka, A; Shimoda, K; Takenaka, K | 1 |
| Fang, L; Hu, N; Li, B; Pan, L; Qin, T; Qu, S; Xiao, Z; Xu, J; Xu, Z; Zhang, H; Zhang, Y | 1 |
| Alvarez-Larrán, A; Cervantes, F; Correa, JG; Hernández-Boluda, JC; Isola, IM; Pereira, A | 1 |
| Aylı, M; Cengiz Seval, G; Özcan, M | 1 |
| Clausen, NT; Hasselbalch, HC; Jensen, BA | 1 |
| Alvarez-Larrán, A; Arellano-Rodrigo, E; Cervantes, F; Domingo, A; Montserrat, E | 1 |
| Okamura, T; Shimoda, K | 1 |
| Harada, N; Haradaa, M; Kamezaki, K; Kinukawa, N; Mizoguchi, H; Niho, Y; Ohyashiki, K; Okamura, T; Omine, M; Ozawa, K; Shide, K; Shimoda, K | 1 |
| Hanson, CA; Huang, J; Li, CY; Mesa, RA; Pardanani, A; Tefferi, A; Wu, W | 1 |
| Matre, R; Nilsen, A | 1 |
| Cherian, R; Dixon, AY; Makdisi, WJ; Stark, SP; Talley, RL; Vanveldhuizen, PJ | 1 |
| Baudard, M; Bourgarit, A; Delmer, A; Legrand, O; Lévy, V; Rio, B; Zittoun, R | 1 |
| Alvarez, A; Cervantes, F; Hernández-Boluda, JC; Montserrat, E; Nadal, E | 1 |
| Canioni, D; Damaj, G; Hermine, O; Lefrère, F; Radford-Weiss, I; Rubio, MT; Valensi, F; Varet, B | 1 |
| Buckley, P; Duffy, TP; Radin, AI | 1 |
| Chabannon, C; Hollard, D; Pegourie, B; Sotto, JJ | 1 |
3 review(s) available for danazol and Primary Myelofibrosis
| Article | Year |
|---|---|
Managing myelofibrosis (MF) that "blasts" through: advancements in the treatment of relapsed/refractory and blast-phase MF.
Topics: Blast Crisis; Danazol; Hematologic Neoplasms; Humans; Primary Myelofibrosis; Recurrence; Rituximab | 2018 |
[Clinical aspects of primary myelofibrosis in Japan].
Topics: Blood Cell Count; Danazol; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Japan; Methenolone; Palliative Care; Prednisolone; Primary Myelofibrosis; Prognosis; Radiotherapy; Spleen; Survival Rate; Transplantation Conditioning | 2014 |
[Primary chronic myelofibrosis in the Japanese population].
Topics: Animals; Antigens, CD34; Asian People; Chromosome Aberrations; Chronic Disease; Cytokines; Danazol; Hematopoietic Stem Cell Transplantation; Humans; Interferon-alpha; Japan; Neovascularization, Pathologic; Primary Myelofibrosis; Prognosis; Severity of Illness Index; Signal Transduction; Splenectomy | 2005 |
10 trial(s) available for danazol and Primary Myelofibrosis
| Article | Year |
|---|---|
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study.
Topics: Anemia; Danazol; Double-Blind Method; Humans; Janus Kinase Inhibitors; Primary Myelofibrosis; Treatment Outcome | 2023 |
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 study.
Topics: Adolescent; Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Danazol; Double-Blind Method; Humans; Janus Kinase Inhibitors; Primary Myelofibrosis | 2023 |
Survival outcomes in myelofibrosis patients treated with ruxolitinib: A population-based cohort study in Sweden and Norway.
Topics: Aged; Busulfan; Danazol; Disease-Free Survival; Female; Follow-Up Studies; Glucocorticoids; Humans; Hydroxyurea; Lenalidomide; Male; Middle Aged; Nitriles; Norway; Pregnancy; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Registries; Survival Rate; Sweden | 2019 |
MOMENTUM: momelotinib vs danazol in patients with myelofibrosis previously treated with JAKi who are symptomatic and anemic.
Topics: Activin Receptors, Type I; Administration, Oral; Adult; Benzamides; Clinical Trials, Phase III as Topic; Danazol; Double-Blind Method; Female; Humans; Janus Kinase 1; Janus Kinase 2; Janus Kinase Inhibitors; Male; Middle Aged; Primary Myelofibrosis; Pyrimidines; Randomized Controlled Trials as Topic; Self Administration; Treatment Outcome | 2021 |
Multicenter phase 2 study of combination therapy with ruxolitinib and danazol in patients with myelofibrosis.
Topics: Adult; Aged; Anemia; Danazol; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nitriles; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Thrombocytopenia; Treatment Outcome | 2017 |
Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia response.
Topics: Adult; Aged; Anemia; Danazol; Female; Humans; Male; Middle Aged; Prednisolone; Primary Myelofibrosis; Thalidomide | 2018 |
Danazol therapy for the anemia of myelofibrosis: assessment of efficacy with current criteria of response and long-term results.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Danazol; Female; Follow-Up Studies; Humans; Male; Middle Aged; Primary Myelofibrosis; Prognosis; Treatment Outcome | 2015 |
Successful treatment of anemia in idiopathic myelofibrosis with recombinant human erythropoietin.
Topics: Aged; Aged, 80 and over; Anemia; Blood Transfusion; Danazol; Drug Therapy, Combination; Erythropoietin; Female; Hemoglobins; Humans; Interferon-alpha; Male; Middle Aged; Primary Myelofibrosis; Recombinant Proteins | 2002 |
The effect of anabolic steroids on anemia in myelofibrosis with myeloid metaplasia: retrospective analysis of 39 patients in Japan.
Topics: Adult; Aged; Aged, 80 and over; Anabolic Agents; Anemia; Blood Transfusion; Chromosome Aberrations; Danazol; Estrogen Antagonists; Female; Hemoglobins; Humans; Male; Methenolone; Middle Aged; Primary Myelofibrosis; Time Factors | 2007 |
Interferon therapy for agnogenic myeloid metaplasia complicated by immune hemolytic anemia.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Antibodies, Anti-Idiotypic; Autoantibodies; Blood Transfusion; Bone Marrow; Combined Modality Therapy; Danazol; Drug Evaluation; Humans; Immunoglobulin G; Interferon Type I; Male; Prednisone; Primary Myelofibrosis; Splenectomy | 1991 |
11 other study(ies) available for danazol and Primary Myelofibrosis
| Article | Year |
|---|---|
Ruxolitinib combined with prednisone, thalidomide and danazol in patients with myelofibrosis: Results of a pilot study.
Topics: Anemia; Danazol; Hemoglobins; Humans; Myeloproliferative Disorders; Nitriles; Pilot Projects; Prednisone; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Thalidomide; Thrombocytopenia; Transaminases; Treatment Outcome | 2022 |
[Comparison of low-dose thalidomide and prednisone combined with or without danazol for the treatment of primary myelofibrosis-associated anemia].
Topics: Adult; Aged; Anemia; Danazol; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prednisone; Primary Myelofibrosis; Retrospective Studies; Thalidomide; Treatment Outcome; Young Adult | 2014 |
Ruxolitinib Treatment in a Patient with Primary Myelofibrosis Resistant to Conventional Therapies and Splenectomy: A Case Report.
Topics: Aged; Aspergillosis; Blood Transfusion; Danazol; Disease Progression; Drug Resistance; Fatal Outcome; Humans; Hydroxyurea; Janus Kinase 2; Lenalidomide; Leukemia, Myeloid, Acute; Male; Nitriles; Primary Myelofibrosis; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Splenectomy; Splenic Infarction; Thalidomide | 2015 |
Efficacy and tolerability of danazol as a treatment for the anaemia of myelofibrosis with myeloid metaplasia: long-term results in 30 patients.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Danazol; Female; Follow-Up Studies; Humans; Male; Middle Aged; Primary Myelofibrosis; Prognosis; Retrospective Studies; Treatment Outcome | 2005 |
Risk factors for leukemic transformation in patients with primary myelofibrosis.
Topics: Cell Transformation, Neoplastic; Danazol; Erythropoietin; Female; Humans; Leukemia; Male; Middle Aged; Primary Myelofibrosis; Risk Factors | 2008 |
Acquired angioedema and hypocompleentemia in a patient with myelofibrosis. Effect of danazol treatment.
Topics: Aged; Angioedema; Complement C1; Complement C1 Inactivator Proteins; Complement C3; Complement C4; Complement Factor B; Danazol; Female; Humans; Pregnadienes; Primary Myelofibrosis | 1980 |
Fatal peliosis of the liver and spleen in a patient with agnogenic myeloid metaplasia treated with danazol.
Topics: Aged; Danazol; Fatal Outcome; Humans; Male; Peliosis Hepatis; Primary Myelofibrosis; Splenic Diseases | 1995 |
Treatment of agnogenic myeloid metaplasia with danazol: a report of four cases.
Topics: Aged; Aged, 80 and over; Anemia; Combined Modality Therapy; Danazol; Erythrocyte Transfusion; Female; Humans; Male; Middle Aged; Primary Myelofibrosis; Splenomegaly | 1996 |
Danazol treatment of idiopathic myelofibrosis with severe anemia.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Danazol; Drug Evaluation; Female; Humans; Male; Middle Aged; Platelet Count; Primary Myelofibrosis; Splenomegaly; Treatment Outcome | 2000 |
Remission of transformed myelodysplastic syndrome with fibrosis after danazol therapy.
Topics: Aged; Danazol; Estrogen Antagonists; Humans; Male; Myelodysplastic Syndromes; Primary Myelofibrosis; Remission Induction | 2002 |
Clinical and hematological improvement in a patient receiving danazol therapy for myelofibrosis with myeloid metaplasia.
Topics: Danazol; Humans; Male; Middle Aged; Pregnadienes; Primary Myelofibrosis | 1990 |